surmount-1 trial tirzepatide weight loss non-diabetic SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes Gastrointestinal tolerability and weight reduction

New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes

Treat a twitchy eye with this easy-to-follow guideEyelid twitching or eye twitching (also called blepharospasms) can be annoying, but thankfully, it is typically a harmless inconvenience the vast majority of the time

Three transformative approachesLifeVantage MindBody GLP-1 supplementation, infrared sauna therapy, and cryotherapy offer benefits

Early-Stage Type 2 Diabetes Management: Helps secure initial glycemic control by establishing smooth post-meal insulin release

Does Ozempic cause blood clots

Researchers are flagging a potential safety concern tied to GLP-1 medications and blood pressure.A new Northwestern Medicine study tracked more than 42,000 adul